Marker Therapeutics (MRKR) Interest Coverage Ratio (2010 - 2014)

Marker Therapeutics (MRKR) has reported Interest Coverage Ratio for 5 consecutive years, with 89.71 the latest figure, recorded in Q3 2014.

• On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 89.71 in Q3 2014; TTM through Sep 2014 was 13.5, a N/A change from a year earlier, with the FY2015 full-year figure at 563.75, changed N/A from the prior year.
• Interest Coverage Ratio was 89.71 for Q3 2014 at Marker Therapeutics, down from 33.64 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 2.69 in Q3 2010 and troughed at 89.71 in Q3 2014.
• A 5-year average of 16.84 and a median of 7.05 in 2011 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio surged 52.06% in 2013 and slumped 910.41% in 2014, its largest moves.
• Over 5 years, Interest Coverage Ratio stood at 2.97 in 2010, then tumbled by 70.04% to 5.05 in 2011, then sank by 520.26% to 31.31 in 2012, then surged by 89.36% to 3.33 in 2013, then slumped by 2594.07% to 89.71 in 2014.
• The last three Interest Coverage Ratio figures came in at 89.71 (Q3 2014), 33.64 (Q1 2014), and 3.33 (Q1 2013), per Business Quant data.